Austràlia - anglès - Department of Health (Therapeutic Goods Administration)

alphapharm pty ltd - calcium carbonate,risedronate sodium -

Austràlia - anglès - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - quinapril hydrochloride, quantity: 21.664 mg (equivalent: quinapril, qty 20 mg) - tablet, film coated - excipient ingredients: magnesium carbonate hydrate; colloidal anhydrous silica; crospovidone; calcium sulfate dihydrate; povidone; magnesium stearate; titanium dioxide; purified talc; iron oxide yellow; xanthan gum; polyvinyl alcohol; lecithin - hypertension: quinapril hydrochloride tablets are indicated for the treatment of hypertension. it may be used alone or in combination with thiazide diuretics. sufficient data have not been provided to support the use of quinapril tablets in renovascular hypertension. congestive heart failure: quinapril hydrochloride tablets are indicated as an adjunctive treatment of mild to moderate congestive heart failure when given concomitantly with a diuretic and/or cardiac glycoside.

Austràlia - anglès - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - quinapril hydrochloride, quantity: 10.832 mg (equivalent: quinapril, qty 10 mg) - tablet, film coated - excipient ingredients: magnesium carbonate hydrate; crospovidone; povidone; colloidal anhydrous silica; calcium sulfate dihydrate; magnesium stearate; titanium dioxide; purified talc; iron oxide yellow; xanthan gum; polyvinyl alcohol; lecithin - hypertension: quinapril hydrochloride tablets are indicated for the treatment of hypertension. it may be used alone or in combination with thiazide diuretics. sufficient data have not been provided to support the use of quinapril tablets in renovascular hypertension. congestive heart failure: quinapril hydrochloride tablets are indicated as an adjunctive treatment of mild to moderate congestive heart failure when given concomitantly with a diuretic and/or cardiac glycoside.

Israel - anglès - Ministry of Health

ferring pharmaceuticals ltd - desmopressin acetate - tablets - desmopressin acetate 0.2 mg - desmopressin - central diabetes insipidus.nocturnal enuresis. treatment of nocturia in adults associated with nocturnal polyuria.

Israel - anglès - Ministry of Health

ferring pharmaceuticals ltd - mesalazine - tablets slow release - mesalazine 1 g - mesalazine - mild to moderate ulcerative colitis. crohn's disease.

Armènia - anglès - Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում

medicamen biotech ltd. - carvedilol - tablets - 6,25mg

Armènia - anglès - Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում

medicamen biotech ltd. - carvedilol - tablets - 12,5mg

Armènia - anglès - Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում

medicamen biotech ltd. - carvedilol - tablets - 25mg

Israel - anglès - Ministry of Health

organon pharma israel ltd., israel - rizatriptan as benzoate - tablets - rizatriptan as benzoate 10 mg - rizatriptan - rizalt is indicated for the acute treatment of migraine attacks with or without aura in adults.

Israel - anglès - Ministry of Health

merck sharp & dohme (israel - 1996) company ltd, israel - ertugliflozin (l-pga); sitagliptin as monohydrate phosphate - film coated tablets - sitagliptin as monohydrate phosphate 100 mg; ertugliflozin (l-pga) 15 mg - sitagliptin and ertugliflozin - steglujan is indicated in adults aged 18 years and older with type 2 diabetes mellitus as an adjunct to diet and exercise to improve glycaemic control:• when metformin and/or a sulphonylurea (su) and one of the monocomponents of steglujan do not provide adequate glycaemic control• in patients already being treated with the combination of ertugliflozin and sitagliptin as separate tablets.